GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Recordati SpA (MIL:REC) » Definitions » Market Cap

Recordati SpA (MIL:REC) Market Cap : €10,552 Mil (As of Dec. 12, 2024)


View and export this data going back to 1984. Start your Free Trial

What is Recordati SpA Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Recordati SpA's share price for the quarter that ended in Sep. 2024 was €50.8. Recordati SpA's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 206 Mil. Therefore, Recordati SpA's market cap for the quarter that ended in Sep. 2024 was €10,465 Mil.

Recordati SpA's quarterly market cap declined from Mar. 2024 (€10,574 Mil) to Jun. 2024 (€10,044 Mil) but then increased from Jun. 2024 (€10,044 Mil) to Sep. 2024 (€10,465 Mil).

Recordati SpA's annual market cap declined from Dec. 2021 (€11,634 Mil) to Dec. 2022 (€7,961 Mil) but then increased from Dec. 2022 (€7,961 Mil) to Dec. 2023 (€10,059 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Recordati SpA's Enterprise Value for Today is €11,874 Mil.


Recordati SpA Market Cap Historical Data

The historical data trend for Recordati SpA's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Recordati SpA Market Cap Chart

Recordati SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,732.54 9,351.40 11,633.97 7,960.84 10,059.27

Recordati SpA Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9,209.90 10,059.27 10,573.94 10,043.99 10,465.10

Competitive Comparison of Recordati SpA's Market Cap

For the Drug Manufacturers - General subindustry, Recordati SpA's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Recordati SpA's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Recordati SpA's Market Cap distribution charts can be found below:

* The bar in red indicates where Recordati SpA's Market Cap falls into.



Recordati SpA Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Recordati SpA's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=€48.83*206.006
=€10,059

Recordati SpA's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=€50.8*206.006
=€10,465

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Recordati SpA  (MIL:REC) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Recordati SpA Market Cap Related Terms

Thank you for viewing the detailed overview of Recordati SpA's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Recordati SpA Business Description

Address
Via Matteo Civitali 1, MIlan, ITA, 20148
Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth. The vast majority of the company's revenue is generated in Italy, followed by the United States, France, and Germany. Recordati reports two operating segments: Specialty and Primary care and Rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment which includes the production of active ingredients.

Recordati SpA Headlines